RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. AstraZeneca
A

AstraZeneca portfolio

AstraZeneca has 2 portfolio companies on record at Recent Funding. Its most recent investment on record is Huma Therapeutics's $80M Series B+ round in July 2024, alongside Leaps by Bayer, Hitachi Ventures and HAT Sicaf. By category, its portfolio leans toward Health and bio (2) and AI agents (1). It has co-invested with Hitachi Ventures, Leaps by Bayer and HAT Sicaf.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $135M.
Latest deal: Huma Therapeutics · Jul 16, 2024.

What AstraZeneca invests in

How AstraZeneca invests

StageDealsCapital in rounds
Series B+ 2 100%$135M

Share is of the 2 rounds on Recent Funding that name AstraZeneca. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

AstraZeneca portfolio companies

CompanyRound with AstraZenecaTotal raisedLatest raise
HHuma Therapeutics
AI agents
Series B+ · $80M$118MSep 11, 2024
round
AAsher Bio
Health and bio
Series B+ · $55M$218MApr 16, 2024
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists AstraZeneca, which is a subset of its real portfolio. API: /api/v1/investors/astrazeneca (get a free API key). More: the most active VC firms and new venture capital funds.